ArticleFrontiers in public health2025
Mandatory food fortification in the eastern Mediterranean region results in reduced prevalence of neural tube defects.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The prevalence of neural tube defects in eastern Ethiopia: A population-based surveillance.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neural Tube Defects (NTDs) are preventable congenital malformations affecting the brain and spinal cord that occur very early in pregnancy, often before gestation is recognized. Globally, at least 20 per 10,000 live births are estimated to be affected by NTDs, although the true prevalence is likely higher due to unreported miscarriages, elective terminations, and gaps in surveillance systems. Mandatory fortification of staple foods with folic acid (Vitamin B9) is widely recognized as the most effective and cost-efficient strategy to reduce the prevalence of NTDs, whereas voluntary dietary supplementation programs have demonstrated limited uptake and population-level impact. Methods: This study employs a situational analysis of mandatory food fortification policies and programs in the Eastern Mediterranean Region. Available epidemiological data on NTD prevalence were reviewed alongside evidence on folic acid fortification effectiveness and program implementation. The analysis also considered the role of surveillance systems, program coverage, and multisectoral engagement across public, private, and civic sectors to assess feasibility, sustainability, and health impact. Results: Estimates of the impact of mandatory food fortification programs in the Eastern Mediterranean Region are constrained by heterogeneous data sources, weak or incomplete surveillance systems, and variable program coverage between and within countries. While countries with established fortification policies show potential reductions in NTD prevalence, inconsistent implementation and monitoring limit the ability to accurately measure outcomes. Insufficient coordination among stakeholders further affects program effectiveness and long-term sustainability. Discussion: Despite strong evidence supporting mandatory folic acid fortification as an effective NTD prevention strategy, significant implementation and monitoring challenges persist in the Eastern Mediterranean Region. Strengthening surveillance systems, improving data quality, and enhancing multisectoral collaboration are critical to translating policy commitments into measurable health outcomes. By integrating epidemiological evidence with implementation insights, this analysis identifies priority areas for improving regional fortification efforts and contributes to broader global strategies aimed at reducing the burden of NTDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.